Significance of lymphangiogenesis in primary tumor and draining lymph nodes during lymphatic metastasis of pancreatic head cancer

Journal of Surgical Oncology

Volumn 102, Issue 7, 2010, Pages 809-815

  Kurahara, Hiroshi ^a   Takao, Sonshin ^a   Shinchi, Hiroyuki ^a   Maemura, Kousei ^a   Mataki, Yuko ^a   Sakoda, Masahiko ^a   Hayashi, Tomomi ^a   Kuwahata, Taisaku ^a   Minami, Koji ^a   Ueno, Shinichi ^a   Natsugoe, Shoji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

immunohistochemistry; lymph node metastasis; lymphatic vessel density; pancreatic cancer

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; LYMPHATIC DRAINAGE; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 78649663237     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21744     Document Type: Article

References (39)

1. Tamagawa E, Ueda M, Takahashi S, et al.: Pancreatic lymph nodal and plexus micrometastases detected by enriched polymerase chain reaction and nonradioisotopic single-strand conformation polymorphism analysis: A new predictive factor for recurrent pancreatic carcinoma. Clin Cancer Res 1997; 3: 2143-2149.
2. Kayahara M, Nagakawa T, Ohta T, et al.: Analysis of paraaortic lymph node involvement in pancreatic carcinoma. Cancer 1999; 85: 583-590.
3. Pedrazzoli S, DiCarlo V, Dionigi R, et al.: Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas. Ann Surg 1998; 228: 508-517.
4. Isaji S, Kawarada Y, Uemoto S:, Classification of pancreatic cancer: Comparison of Japanese and UICC classifications. Pancreas 2004; 28: 231-234.
5. Demeure MJ, Doffek KM, Komorowski RA, Wilson SD:, Adenocarcinoma of the pancreas: Detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay. Cancer 1998; 83: 1328-1334.
6. Niedergethmann M, Rexin M, Hildenbrand R, et al.: Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma. Am J Surg Pathol 2002; 26: 1578-1587.
7. Kurahara H, Takao S, Maemura K, et al.: Impact of lymph node micrometastasis in patients with pancreatic head cancer. World J Surg 2007; 31: 483-490.
8. Bouvet M, Wang J, Nardin SR, et al.: Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res 2002; 62: 1534-1540.
9. Hanahan D, Weinberg RA:, The hallmarks of cancer. Cell 2000; 100: 57-70.
10. Joukov V, Pajusola K, Kaipainen A, et al.: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996; 15: 290-298.
11. Orlandini M, Marconcini L, Ferruzzi R, Oliviero S:, Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc Natl Acad Sci USA 1996; 93: 11675-11680.
12. Banerji S, Ni J, Wang SX, et al.: LYVE-1, new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999; 144: 789-801.
13. Wilge JT, Oliver C:, PROX-1 function is required for the development of the murine lymphatic system. Cell 1999; 98: 769-778.
14. Breiteneder-Geleff S, Soleiman A, Kowalski H, et al.: Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 1999; 154: 385-394.
15. Kahn HJ, Bailey D, Marks A:, Monoclonal antibody D2-40, a new markers of lymphatic endothelium, react with Kaposi's sarcoma and a subset of angiosarcomas. Modern Pathol 2002; 15: 434-440.
16. Jeltsch M, Kaipainen A, Joukov V, et al.: Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997; 276: 1423-1425.
17. Skobe M, Hawighorst T, Jackson DG, et al.: Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001; 7: 192-198.
18. Karpanen T, Egeblad M, Karkkainen MJ, et al.: Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 2001; 61: 1786-1790. (Pubitemid 32691984)
19. Mandriota SJ, Jussila L, Jeltsch M, et al.: Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 2001; 20: 672-682. (Pubitemid 32167632)
20. Zhang D, Li B, Shi J, et al.: Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein. Cancer Res 2010; 70: 2495-2503.
21. Krishnan J, Kirkin V, Steffen A, et al.: Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats. Cancer Res 2003; 63: 713-722.
22. Lee K, Park DJ, Choo G, et al.: Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma. Ann Surg Oncol 2010; 17: 73-80.
23. Thelen A, Scholz A, Weichert W, et al.: Tumor-associated angiogenesis and lymphangiogenesis correlate with progression of intrahepatic cholangiocarcinoma. Am J Gastroenterol 2010; 105: 1123-1132.
24. Beasley NJ, Prevo R, Banerji S, et al.: Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 2002; 62: 1315-1320.
25. Straume O, Jackson DG, Akslen LA:, Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 2003; 9: 250-256.
26. Qian CN, Berghuis B, Tsarfatty G, et al.: Preparing the "soil": The primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. Cancer Res 2006; 66: 10365-10376.
27. Hirakawa S, Brown LF, Kodama S, et al.: VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 2007; 109: 1010-1017.
28. Harrell MI, Iritani BM, Ruddell A:, Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol 2007; 170: 774-786.
29. Sobin LH, Wittekind CH:, International Union Against Cancer. TNM classification of malignant tumours, 6th edition. New York: Wiley-Liss, Inc.; 2002.
30. Kahn HJ, Marks A:, A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 2002; 82: 1255-1257.
31. Fogt F, Zimmerman RL, Ross HM, et al.: Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40. Oncol Rep 2004; 11: 47-50.
32. Kurahara H, Takao S, Maemura K, et al.: Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: Its relationship to lymph node metastasis. Clin Cancer Res 2004; 10: 8413-8420.
33. Birner P, Schindl M, Obermair A, et al.: Lymphatic microvessel density as a novel prognostic factor in early-stage invasive cervical cancer. Int J Cancer 2001; 95: 29-33.
34. Padera TP, Kadambi A, di Tomaso E, et al.: Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002; 296: 1883-1886.
35. Leu AJ, Berk DA, Lympoussaki A, et al.: Absence of functional lymphatics within a murine sarcoma; A molecular and functional evaluation. Cancer Res 2000; 60: 4324-4327.
36. He Y, Rajantie I, Pajusola K, et al.: Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 2005; 65: 4739-4746.
37. Van den Eynden GG, Vandenverghe MK, van Dam PJ, et al.: Increased sentinel lymph node lymphaniogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node. Clin Cancer Res 2007; 13: 5391-5397.
38. Nagakawa T, Kobayashi H, Ueno K, et al.: Clinical study of lymphatic flow to the paraaortic lymph nodes in carcinoma of the head of the pancreas. Cancer 1994; 73: 1155-1162.
39. Ueda M, Hung YC, Terai Y, et al.: Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas. Clin Cancer Res 2005; 11: 3225-3232.